Neva offers discovery, development and early-stage processing services – all in a controlled pharmaceutical setting to enhance data integrity and reliability to support future regulatory and intellectual property (IP) uses.

Discovery: Neva can assist with cell culture, purification, and/or material characterization for large molecule candidate screening.

Pre-IND: Neva can support cell culture, purification and/or testing of pre-clinical/IND enabling materials.

Phase 1: Neva can also help prepare Phase 1 materials according to the FDA guidance for Current Good Manufacturing Practices for Phase 1 Investigational Drugs.